Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has raised CNY 20 million in a round of funding on August 21, 2023. The transaction included participation from new investors, Anhui Huaheng Biotechnology Co., Ltd. and Suzhou Kaifeng Zhengde Investment Management Co., Ltd.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
94.78 CNY | -4.94% | -10.03% | -24.72% |
Apr. 22 | Anhui Huaheng Biotechnology's Q1 Profit Jumps 7% | MT |
Apr. 22 | Anhui Huaheng Biotechnology's 2023 Profit Jumps 40% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-24.72% | 2.06B | |
-5.67% | 27.45B | |
+18.78% | 24.56B | |
+5.34% | 11.01B | |
+11.49% | 5.11B | |
+14.97% | 4.33B | |
-13.08% | 3.62B | |
+5.01% | 3.5B | |
-5.98% | 2.8B | |
+25.30% | 2.75B |
- Stock Market
- Equities
- 688639 Stock
- News Anhui Huaheng Biotechnology Co., Ltd.
- Wuhan Ruijiakang Biotechnology Co., Ltd. announced that it has received CNY 20 million in funding from Anhui Huaheng Biotechnology Co., Ltd., Suzhou Kaifeng Zhengde Investment Management Co., Ltd.